Associated Capital Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Associated Capital Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $11.59M | Mar 9, 2018 |
| FY2017 | Sep 30, 2017 | $5.25M | Mar 9, 2018 |
| FY2017 | Jun 30, 2017 | $5.10M | Mar 9, 2018 |
| FY2017 | Mar 31, 2017 | $4.99M | Mar 9, 2018 |
| FY2017 | Dec 31, 2016 | $16.30M | Mar 9, 2018 |
| FY2017 | Sep 30, 2016 | $5.45M | Mar 9, 2018 |
| FY2017 | Jun 30, 2016 | $4.96M | Mar 9, 2018 |
| FY2017 | Mar 31, 2016 | $4.52M | Mar 9, 2018 |
| FY2016 | Dec 31, 2015 | $9.00M | Mar 14, 2017 |
| FY2016 | Sep 30, 2015 | $4.69M | Mar 14, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $13.18M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $12.68M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $15.23M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $20.92M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $18.98M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $22.21M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $22.78M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $26.92M | Mar 8, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $44.33M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $37.45M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | ($48.91M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $59.20M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $18.82M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $39.19M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($58.10M) | Mar 16, 2020 |
| FY2017 | Dec 31, 2017 | $15.80M | Mar 9, 2018 |
| FY2017 | Sep 30, 2017 | $1.52M | Mar 9, 2018 |
| FY2017 | Jun 30, 2017 | $4.60M | Mar 9, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($18.75M) | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | ($16.95M) | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | ($11.26M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | ($19.08M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($12.47M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($13.26M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($13.48M) | Mar 16, 2020 |
| FY2017 | Dec 31, 2017 | ($3.49M) | Mar 9, 2018 |
| FY2017 | Sep 30, 2017 | ($6.11M) | Mar 9, 2018 |
| FY2017 | Jun 30, 2017 | ($6.45M) | Mar 9, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $26.87M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $145.08M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | ($70.55M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $238.19M | Mar 16, 2023 |
| FY2019 | Dec 31, 2019 | ($44.33M) | Mar 16, 2020 |
| FY2019 | Dec 31, 2018 | $76.98M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | ($67.62M) | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $6.59M | Mar 9, 2018 |
| FY2017 | Dec 31, 2015 | ($47.35M) | Mar 9, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $935.29M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $943.80M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $927.69M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.20B | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.17B | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.01B | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $954.43M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $1.01B | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $952.60M | Mar 9, 2018 |
| FY2016 | Dec 31, 2015 | $836.75M | Mar 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $36.99M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $30.72M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $27.30M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $65.53M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $66.33M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $63.09M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $38.39M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $42.54M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $74.35M | Mar 9, 2018 |
| FY2016 | Dec 31, 2015 | $79.46M | Mar 14, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $892.71M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $906.98M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $890.20M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $937.10M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $898.94M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $896.43M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $866.25M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $918.15M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $874.02M | Mar 9, 2018 |
| FY2016 | Dec 31, 2015 | $749.20M | Mar 14, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.52M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $3.52M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $3.52M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $3.52M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $3.52M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $3.52M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $3.52M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $3.42M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $3.42M | Mar 9, 2018 |
| FY2016 | Dec 31, 2015 | $3.25M | Mar 14, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $45.81M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $48.23M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $15.13M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $68.44M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $13.65M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($701.0K) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($39.89M) | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $13.80M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $7.33M | Mar 9, 2018 |
| FY2016 | Dec 31, 2015 | $2.07M | Mar 14, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $299.55M | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $317.49M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $218.46M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $319.05M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $39.51M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $342.00M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $409.56M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $293.11M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $314.09M | Mar 9, 2018 |
| FY2017 | Dec 31, 2015 | $205.75M | Mar 9, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 2 | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | 1 | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | 2 | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 1 | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | (2) | Mar 16, 2020 |
| FY2017 | Dec 31, 2017 | 0 | Mar 9, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 9, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Mar 9, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 2 | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | 1 | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | 2 | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 1 | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | (2) | Mar 16, 2020 |
| FY2017 | Dec 31, 2017 | 0 | Mar 9, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 9, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Mar 9, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 21,538 | Mar 21, 2024 |
| FY2023 | Dec 31, 2022 | 21,990 | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | 22.06M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 22.27M | Mar 17, 2022 |